Work

Canertinib as an FLT3 Inhibitor with Potent Activity Against FLT3-Mutated and AC220-Resistant Acute Myeloid Leukemia

Year: 2025

Type: article

Source: Journal of Visualized Experiments

DOI: 10.3791/69655

Authors: Hongfeng Pang, Chaoling Wan, Maofeng Zhang, Shuaishuai Ge, Yuanhong Huang, Chengqiao Qiu, Shengli Xue, Depei Wu, Songbai Liu

Institutions: First Affiliated Hospital of Soochow University, Suzhou Vocational Health College

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417066697

FWCI:

Cites:

Cited by:

Related to: